Cantor Fitzgerald analyst Steven Halper reiterated a Buy rating on Ehealth (NASDAQ: EHTH) yesterday and set a price target of $39. The company’s shares closed yesterday at $28.38.
Halper observed:
“. We reiterate our Overweight rating on EHTH shares and our $39 price target. After the close on Thursday, October 25, EHTH reported its 3Q18 results. The company’s total revenue was above our estimate and FactSet consensus. The non-GAAP loss per share was also better than consensus expectations. The results were solid, but the company stressed the importance of its salesforce and digital marketing strategy as the Period (AEP) commenced on October 15. EHTH continues to stabilize its IFP segment and focus on alternative options to ACA plans. The company also reiterated its previously- established guidance metrics for full year 2018.”
According to TipRanks.com, Halper is a top 25 analyst with an average return of 22.2% and a 71.8% success rate. Halper covers the Services sector, focusing on stocks such as WellCare Health Plans, Tivity Health Inc, and Hms Holdings Corp.
Ehealth has an analyst consensus of Moderate Buy, with a price target consensus of $29.50.
See today’s analyst top recommended stocks >>
The company has a one-year high of $32.96 and a one-year low of $13.61. Currently, Ehealth has an average volume of 181.3K.
Based on the recent corporate insider activity of 60 insiders, corporate insider sentiment is negative on the stock. Most recently, in August 2018, Jack Oliver, a Director at EHTH sold 30,750 shares for a total of $762,953.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
eHealth, Inc. engages in the provision of Internet-based health insurance agency services for individuals, families, and small businesses. It operates through the Medicare and Individual, Family, and Small Business segment. The Medicare segment consists primarily of commissions earned from sale of Medicare-related health insurance plans.
